Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
15 mai 2024 18h00 HE
|
Vaccinex, Inc.
Last patient last visit in SIGNAL-AD Phase 2a study of pepinemab treatment for Alzheimer’s Disease in early June 2024. $8.2 million of new financing in Q1.
Christina Lake Cannabis Provides Bi-Weekly Update on Status of MCTO
15 mai 2024 17h00 HE
|
Christina Lake Cannabis Corp.
VANCOUVER, British Columbia, May 15, 2024 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. ("CLC" or the "Company") (CSE: CLC) is providing an update with respect to the expected timeline for...
American Oncology Network, Inc. Announces First Quarter 2024 Financial Results
15 mai 2024 16h47 HE
|
American Oncology Network
First Quarter 2024 Highlights Revenue of $364.3 million increased by 20.0% compared to the prior year quarter Patient encounter growth of 7.1% as compared to the prior year quarter Added 17 new...
Battalion Oil Corporation Announces First Quarter 2024 Financial and Operating Results
15 mai 2024 16h32 HE
|
Battalion Oil Corporation
HOUSTON, May 15, 2024 (GLOBE NEWSWIRE) -- Battalion Oil Corporation (NYSE American: BATL, “Battalion” or the “Company”) today announced financial and operating results for the first quarter of 2024....
Digital Media Solutions, Inc. Announces Q1 2024 Financial Results
15 mai 2024 16h30 HE
|
Digital Media Solutions
First-quarter net revenue of $70.7 millionFirst-quarter gross margin of 20.2% and Variable Marketing Margin (VMM) of 23.7% CLEARWATER, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- Digital Media...
Precision Optics Reports Third Quarter Fiscal Year 2024 Financial Results
15 mai 2024 16h30 HE
|
Precision Optics Corporation
GARDNER, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense...
Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
15 mai 2024 16h15 HE
|
Fortress Biotech, Inc.
Fortress‘ late-stage pipeline continues to advance and may generate up to three regulatory approvals on NDAs and BLAs in the next 12 months and potentially a fourth BLA filing as early as 2025 FDA...
INVO Reports Record First Quarter 2024 Financial Results
15 mai 2024 16h15 HE
|
INVO Bioscience
SARASOTA, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced...
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
15 mai 2024 16h10 HE
|
Agile Therapeutics, Inc.
First Quarter Net Revenue Increased 58% and Factory Sales Increased 3% from Fourth Quarter 2023 Twirla First Quarter 2024 Demand Rebounded 18% from Fourth Quarter 2023 PRINCETON, N.J., May 15,...
Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
15 mai 2024 16h05 HE
|
Athira Pharma, Inc.
Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates